MAP-kinase pathway up or down? Just look at the skin of your patients!

Melanoma Res. 2014 Oct;24(5):421-3. doi: 10.1097/CMR.0000000000000114.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acneiform Eruptions / complications*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Imidazoles / administration & dosage*
  • Indoles / therapeutic use*
  • MAP Kinase Kinase Kinases / metabolism*
  • Melanoma / complications*
  • Melanoma / drug therapy*
  • Oximes / administration & dosage*
  • Proto-Oncogene Proteins B-raf / metabolism*
  • Pyridones / administration & dosage*
  • Pyrimidinones / administration & dosage*
  • Skin Neoplasms / complications*
  • Skin Neoplasms / drug therapy*
  • Sulfonamides / therapeutic use*
  • Vemurafenib

Substances

  • Imidazoles
  • Indoles
  • Oximes
  • Pyridones
  • Pyrimidinones
  • Sulfonamides
  • Vemurafenib
  • trametinib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • MAP Kinase Kinase Kinases
  • dabrafenib